# clm_8C160359CC75

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: quarterly_research_and_development  
value: 2,321,000,000 United States dollar  
valid_from: 2022-06-30  
valid_to: 2022-09-30  
published: 2022-07-27  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0295F3B65E36  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb quarterly research and development: 2,321,000,000 United States dollar", as of 2022-06-30 (until 2022-09-30). Claim clm_8C160359CC75, https://asof.is/claim/clm_8C160359CC75, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2022, filed 2022-07-27  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm (primary, SEC EDGAR 10-Q Q2 FY2022, published 2022-07-27)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,260,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_8C160359CC75](/claim/clm_8C160359CC75.md) | [clm_2653771A828C](/claim/clm_2653771A828C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.